Fulgent Genetics, Inc. (NASDAQ: FLGT) reported Q1 EPS of $0.04, $0.12 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $73.5 million versus the consensus estimate of $73.89 million.

GUIDANCE:

Fulgent Genetics, Inc. sees FY2025 EPS of ~($0.65), versus the consensus of ($0.66). Fulgent Genetics, Inc. sees FY2025 revenue of ~$310 million, versus the consensus of $310.4 million.

For earnings history and earnings-related data on Fulgent Genetics, Inc. (FLGT) click here.